Thank you for your participation!
Joseph B. Martin Conference Center
at Harvard Medical School
77 Avenue Louis Pasteur, Boston, MA 02115
About the Conference
The First Stop for Growing Your
The 15th Annual Trans-Pacific Health Sciences Dialogue is a meeting for biopharmaceutical industry executives and business development executives who want to accelerate, explore and develop collaborations and partnerships with their counterparts in the most important Trans-Pacific health care markets including Japan, China, South Korea and North America.
This is a must-attend meeting for executives who have, or want to develop, a Trans-Pacific strategy. The event has developed a well-earned reputation as the best place for biopharma companies seeking to forge Trans-Pacific ventures to start exploring their options. Attendees come away with a broad overview and insights they simply will not get in other meetings.
Take a look at some photos from the 2016 Trans-Pacific Health Sciences Dialogue!
Industry News from FiercePharmaAsia
- Merck's Gardasil preps for head-to-head with GlaxoSmithKline’s Cervarix in China, with big sales targets aheadGlaxoSmithKline's Cervarix may have been the first HPV shot approved in mainland China, but it might just fall behind. Cervarix hasn't rolled out there yet, and as of Monday, Merck's Gardasil boasts its own green light. Cue a market showdown, with Merck in line for $166 million in first-year sales.
- Boehringer Ingelheim has China biologics plant up and runningGermany’s Boehringer Ingelheim several years ago decided it wanted to expand its biologics contract manufacturing business and bet that China was the place to target with its huge population and growing appetite for the latest meds. The company has now opened a €70 million facility in Shanghai to capitalize on that bet.
Who Should Attend
The Trans-Pacific Health Sciences Dialogue is an event for biopharmaceutical executives, KOLs, select industry advisors and members of the financial community with a strategic interest in Trans-Pacific collaboration or investment.